Analysts Offer Insights on NA Companies: Rubrik, Inc. Class A (NYSE: RBRK) and CG Oncology, Inc. (NASDAQ: CGON)We think the disconnect between short-term sentiment and fundamentals should create opportunity for investors. With ARR growth still strong, margins inflecting, competitive dynamics favorable, and new vectors (identity, DSPM, AI) gaining traction, Rubrik looks more compelling post-pullback. At ~8x EV/CY27E, we continue to see RBRK as a high-conviction idea on cyber-resilience and are naming as a bullish Fresh Pick. Sell-off dynamics vs. fundamental strength: Near term, the sell-off was driven less by deterioration in fundamentals and more by heightened short-term expectations/sentiment (couple of outliers) and VC- distribution event driving outsized volatility. Importantly, the fundamentals remain intact as cloud ARR (forward indicator) accelerated +57% y/y to $1.06B, FCF margin hit 19%, and contribution margin expanded ~1800bps y/y.